Related references
Note: Only part of the references are listed.Short- and Longterm Glycemic Control of Streptozotocin-Induced Diabetic Rats Using Different Insulin Preparations
Gerd Luippold et al.
PLOS ONE (2016)
A Soluble Guanylate Cyclase Activator Inhibits the Progression of Diabetic Nephropathy in the ZSF1 Rat
Carine M. Boustany-Kari et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
Csaba Matyas et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Renal effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
Johannes-Peter Stasch et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
Dexamethasone-dependent modulation of cyclic GMP synthesis in podocytes
Barbara Lewko et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2015)
Full-length soluble urokinase plasminogen activator receptor down-modulates nephrin expression in podocytes
Massimo Alfano et al.
SCIENTIFIC REPORTS (2015)
Stimulation of the soluble guanylate cyclase (sGC) inhibits fibrosis by blocking non-canonical TGFβ signalling
Christian Beyer et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Chronic Activation of Heme Free Guanylate Cyclase Leads to Renal Protection in Dahl Salt-Sensitive Rats
Linda S. Hoffmann et al.
PLOS ONE (2015)
Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis
Wenpeng Cui et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Divergent functions of the Rho GTPases Rac1 and Cdc42 in podocyte injury
Simone M. Blattner et al.
KIDNEY INTERNATIONAL (2013)
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha et al.
LANCET (2013)
Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3′,5′ guanosine monophosphate (cGMP) level in podocytes
Lilla Fang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Semi-automated quantitative image analysis of podocyte desmin immunoreactivity as a sensitive marker for acute glomerular damage in the rat puromycin aminonucleoside nephrosis (PAN) model
Annika Herrmann et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Effects of Stimulation of Soluble Guanylate Cyclase on Diabetic Nephropathy in Diabetic eNOS Knockout Mice on Top of Angiotensin II Receptor Blockade
Ina M. Ott et al.
PLOS ONE (2012)
Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats
Yoshihiro Kuno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Johannes-Peter Stasch et al.
CIRCULATION (2011)
Transforming growth factor-beta type 1 receptor (ALK5) and Smad proteins mediate TIMP-1 and collagen synthesis in experimental intestinal fibrosis
Carlos Medina et al.
JOURNAL OF PATHOLOGY (2011)
Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models
Yuliya Sharkovska et al.
JOURNAL OF HYPERTENSION (2010)
Effects of Sildenafil on Oxidative and Inflammatory Injuries of the Kidney in Streptozotocin-Induced Diabetic Rats
Kyung-Hwan Jeong et al.
AMERICAN JOURNAL OF NEPHROLOGY (2009)
Nitric Oxide-Independent Vasodilator Rescues Heme-Oxidized Soluble Guanylate Cyclase From Proteasomal Degradation
Sabine Meurer et al.
CIRCULATION RESEARCH (2009)
Mechanical forces and TGFβ1 reduce podocyte adhesion through α3β1 integrin downregulation
Cecile Dessapt et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Proteinuria in diabetic kidney disease: A mechanistic viewpoint
J. A. Jefferson et al.
KIDNEY INTERNATIONAL (2008)
Osmotic polyuria: an overlooked mechanism in diabetic nephropathy
Shinong Wang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production
Sharma Prabhakar et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Sildenafil improves immediate posttransplant parameters in warm-ischemic kidney transplants: Experimental study
E. Lledo-Garcia et al.
TRANSPLANTATION PROCEEDINGS (2007)
NO-independent activation of soluble guanylate cyclase prevents disease progression in rats with 5/6 nephrectomy
Philipp Kalk et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential
Oleg V. Evgenov et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
TGF-β concentration specifies differential signaling profiles of growth arrest/differentiation land apoptosis in podocytes
DT Wu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Early treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage
B Rodríguez-Iturbe et al.
KIDNEY INTERNATIONAL (2005)
From the periphery of the glomerular capillary wall toward the center of disease - Podocyte injury comes of age in diabetic nephropathy
G Wolf et al.
DIABETES (2005)
NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy
M Satoh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies
P Pacher et al.
CURRENT MEDICINAL CHEMISTRY (2005)
Glucose up-regulates thrombospondin 1 gene transcription and transforming growth factor-β activity through antagonism of cGMP-dependent protein kinase repression via upstream stimulatory factor 2
SX Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Role of nitric oxide in diabetic nephropathy
SS Prabhakar
SEMINARS IN NEPHROLOGY (2004)
Early glomerular filtration defect and severe renal disease in podocin-deficient mice
S Roselli et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
The renin-angiotensin-aidosterone system: Cardiorenal effects and implications for renal and cardiovascular disease states
UC Brewster et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2003)
Cross-talk between ERK MAP kinase and Smad-signaling pathways enhances TGF-β dependent responses in human mesangial cells
T Hayashida et al.
FASEB JOURNAL (2003)
The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-β1
MC Hall et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Effects of high glucose and TGF-β1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes
MC Iglesias-de la Cruz et al.
KIDNEY INTERNATIONAL (2002)
Nitric oxide and cGMP-dependent protein kinase regulation of glucose-mediated thrombospondin 1-dependent transforming growth factor-β activation in mesangial cells
SX Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
High glucose-induced hypertrophy of mesangial cells requires p27Kip1, an inhibitor of cyclin-dependent kinases
G Wolf et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death
H Putaala et al.
HUMAN MOLECULAR GENETICS (2001)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
